Literature DB >> 21263438

Cognitive function, dementia and type 2 diabetes mellitus in the elderly.

Mark W J Strachan1, Rebecca M Reynolds, Riccardo E Marioni, Jacqueline F Price.   

Abstract

Increasing numbers of people are developing type 2 diabetes mellitus, but interventions to prevent and treat the classic microvascular and macrovascular complications have improved, so that people are living longer with the condition. This trend means that novel complications of type 2 diabetes mellitus, which are not targeted by current management strategies, could start to emerge. Cognitive impairment and dementia could come into this category. Type 2 diabetes mellitus is associated with a 1.5-2.5-fold increased risk of dementia. The etiology of dementia and cognitive impairment in people with type 2 diabetes mellitus is probably multifactorial. Chronic hyperglycemia is implicated, perhaps by promoting the development of cerebral microvascular disease. Data suggest that the brains of older people with type 2 diabetes mellitus might be vulnerable to the effects of recurrent, severe hypoglycemia. Other possible moderators of cognitive function include inflammatory mediators, rheological factors and dysregulation of the hypothalamic-pituitary-adrenal axis. Cognitive function should now be included as a standard end point in randomized trials of therapeutic interventions in patients with type 2 diabetes mellitus.

Entities:  

Mesh:

Year:  2011        PMID: 21263438     DOI: 10.1038/nrendo.2010.228

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


  82 in total

1.  Is sticky blood a treatable determinant of cognitive decline and of dementia?

Authors:  G D Lowe
Journal:  Age Ageing       Date:  2001-03       Impact factor: 10.668

2.  Elevated late-night salivary cortisol levels in elderly male type 2 diabetic veterans.

Authors:  Hau Liu; Dena M Bravata; Josel Cabaccan; Hershel Raff; Elisabeth Ryzen
Journal:  Clin Endocrinol (Oxf)       Date:  2005-12       Impact factor: 3.478

3.  Peripheral levels of fibrinogen, C-reactive protein, and plasma viscosity predict future cognitive decline in individuals without dementia.

Authors:  Riccardo E Marioni; Marlene C Stewart; Gordon D Murray; Ian J Deary; F Gerry R Fowkes; Gordon D O Lowe; Ann Rumley; Jackie F Price
Journal:  Psychosom Med       Date:  2009-08-06       Impact factor: 4.312

4.  Hypercortisolism in diabetes mellitus.

Authors:  O G Cameron; B Thomas; D Tiongco; M Hariharan; J F Greden
Journal:  Diabetes Care       Date:  1987 Sep-Oct       Impact factor: 19.112

5.  The metabolic syndrome, inflammation, and risk of cognitive decline.

Authors:  Kristine Yaffe; Alka Kanaya; Karla Lindquist; Eleanor M Simonsick; Tamara Harris; Ronald I Shorr; Frances A Tylavsky; Anne B Newman
Journal:  JAMA       Date:  2004-11-10       Impact factor: 56.272

6.  Combined receptor antagonist stimulation of the hypothalamic-pituitary-adrenal axis test identifies impaired negative feedback sensitivity to cortisol in obese men.

Authors:  Cecilia Mattsson; Rebecca M Reynolds; Kotryna Simonyte; Tommy Olsson; Brian R Walker
Journal:  J Clin Endocrinol Metab       Date:  2009-01-13       Impact factor: 5.958

7.  Global prevalence of diabetes: estimates for the year 2000 and projections for 2030.

Authors:  Sarah Wild; Gojka Roglic; Anders Green; Richard Sicree; Hilary King
Journal:  Diabetes Care       Date:  2004-05       Impact factor: 19.112

8.  Contribution of metabolic syndrome components to cognition in older individuals.

Authors:  Miranda G Dik; Cees Jonker; Hannie C Comijs; Dorly J H Deeg; Astrid Kok; Kristine Yaffe; Brenda W Penninx
Journal:  Diabetes Care       Date:  2007-06-11       Impact factor: 19.112

9.  Association of C-reactive protein with type 2 diabetes: prospective analysis and meta-analysis.

Authors:  C C Lee; A I Adler; M S Sandhu; S J Sharp; N G Forouhi; S Erqou; R Luben; S Bingham; K T Khaw; N J Wareham
Journal:  Diabetologia       Date:  2009-03-27       Impact factor: 10.122

10.  Relationship between baseline glycemic control and cognitive function in individuals with type 2 diabetes and other cardiovascular risk factors: the action to control cardiovascular risk in diabetes-memory in diabetes (ACCORD-MIND) trial.

Authors:  Tali Cukierman-Yaffe; Hertzel C Gerstein; Jeff D Williamson; Ronald M Lazar; Laura Lovato; Michael E Miller; Laura H Coker; Anne Murray; Mark D Sullivan; Santica M Marcovina; Lenore J Launer
Journal:  Diabetes Care       Date:  2009-02       Impact factor: 17.152

View more
  141 in total

1.  Effects of Comorbid Depression and Diabetes Mellitus on Cognitive Decline in Older Mexican Americans.

Authors:  Brian Downer; Benjamin N Vickers; Soham Al Snih; Mukaila Raji; Kyriakos S Markides
Journal:  J Am Geriatr Soc       Date:  2016-01       Impact factor: 5.562

2.  [Diabetes and dementia].

Authors:  A Bahrmann; P Bahrmann; T Kubiak; D Kopf; P Oster; C C Sieber; W G Daniel
Journal:  Z Gerontol Geriatr       Date:  2012-01-27       Impact factor: 1.281

Review 3.  Type 2 diabetes and cognitive impairment: contributions from neuroimaging.

Authors:  John P Ryan; David F Fine; Caterina Rosano
Journal:  J Geriatr Psychiatry Neurol       Date:  2014-01-05       Impact factor: 2.680

4.  Galantamine alleviates inflammation and insulin resistance in patients with metabolic syndrome in a randomized trial.

Authors:  Fernanda M Consolim-Colombo; Carine T Sangaleti; Fernando O Costa; Tercio L Morais; Heno F Lopes; Josiane M Motta; Maria C Irigoyen; Luiz A Bortoloto; Carlos Eduardo Rochitte; Yael Tobi Harris; Sanjaya K Satapathy; Peder S Olofsson; Meredith Akerman; Sangeeta S Chavan; Meggan MacKay; Douglas P Barnaby; Martin L Lesser; Jesse Roth; Kevin J Tracey; Valentin A Pavlov
Journal:  JCI Insight       Date:  2017-07-20

5.  The association between cognitive decline and incident depressive symptoms in a sample of older Puerto Rican adults with diabetes.

Authors:  Tyler Bell; Ana Luisa Dávila; Olivio Clay; Kyriakos S Markides; Ross Andel; Michael Crowe
Journal:  Int Psychogeriatr       Date:  2017-05-17       Impact factor: 3.878

6.  Diabetes is associated with lower global cognitive function in schizophrenia.

Authors:  Yoichiro Takayanagi; Nicola G Cascella; Akira Sawa; William W Eaton
Journal:  Schizophr Res       Date:  2012-09-29       Impact factor: 4.939

7.  Diabetes and the elderly brain: sweet memories?

Authors:  Katherine Samaras; Perminder S Sachdev
Journal:  Ther Adv Endocrinol Metab       Date:  2012-12       Impact factor: 3.565

8.  High-Normal Adolescent Fasting Plasma Glucose Is Associated With Poorer Midlife Brain Health: Bogalusa Heart Study.

Authors:  Owen Carmichael; Patrick Stuchlik; Sreekrishna Pillai; Geert-Jan Biessels; Ram Dhullipudi; Anna Madden-Rusnak; Shane Martin; Daniel S Hsia; Vivian Fonseca; Lydia Bazzano
Journal:  J Clin Endocrinol Metab       Date:  2019-10-01       Impact factor: 5.958

9.  Vascular complications of diabetes: natural history and corresponding risks of dementia in a national cohort of adults with diabetes.

Authors:  Po-Yin Chang; I-T Ing Wang; Chern-En Chiang; Chen-Huan Chen; Wan-Yu Yeh; Victor W Henderson; Yi-Wen Tsai; Hao-Min Cheng
Journal:  Acta Diabetol       Date:  2021-02-23       Impact factor: 4.280

Review 10.  Diabetes, adult neurogenesis and brain remodeling: New insights from rodent and zebrafish models.

Authors:  Anne-Claire Dorsemans; David Couret; Anaïs Hoarau; Olivier Meilhac; Christian Lefebvre d'Hellencourt; Nicolas Diotel
Journal:  Neurogenesis (Austin)       Date:  2017-01-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.